Table 1.

Summary of Studies Performed

Note.—AT = acquisition time, C1 = category 1, C2 = category 2, C6 = category 6, C8 = category 8, dose = contrast agent dose, FT = frame time, main RA = evaluation of main renal artery, SR = spatial resolution, ST = start time for acquisition after injection, timing = evaluation of timing information, VE = evaluation of venous enhancement, VV = voxel volume. All subjects received a total of 20 mL of the contrast agent except patients 3 and 6, who received a total of 12 mL.

^*Values are for reviewer 1 and reviewer 2, respectively.